Literature DB >> 20720159

Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}.

Feng Guan1, Lana Schaffer, Kazuko Handa, Sen-Itiroh Hakomori.   

Abstract

The epithelial-to-mesenchymal transition (EMT) is a basic cellular process that plays a key role in normal embryonic development and in cancer progression/metastasis. Our previous study indicated that EMT processes of mouse and human epithelial cells induced by TGF-β display clear reduction of gangliotetraosylceramide (Gg4) and ganglioside GM2, suggesting a close association of glycosphingolipids (GSLs) with EMT. In the present study, using normal murine mammary gland (NMuMG) cells, we found that levels of Gg4 and of mRNA for the UDP-Gal:β1-3galactosyltransferase-4 (β3GalT4) gene, responsible for reduction of Gg4, were reduced in EMT induced by hypoxia (∼1% O(2)) or CoCl(2) (hypoxia mimic), similarly to that for TGF-β-induced EMT. An increase in the Gg4 level by its exogenous addition or by transfection of the β3GalT4 gene inhibited the hypoxia-induced or TGF-β-induced EMT process, including changes in epithelial cell morphology, enhanced motility, and associated changes in epithelial vs. mesenchymal molecules. We also found that Gg4 is closely associated with E-cadherin and β-catenin. These results suggest that the β3GalT4 gene, responsible for Gg4 expression, is down-regulated in EMT; and Gg4 has a regulatory function in the EMT process in NMuMG cells, possibly through interaction with epithelial molecules important to maintain epithelial cell membrane organization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720159      PMCID: PMC2992377          DOI: 10.1096/fj.10-162107

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

Review 1.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 2.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.

Authors:  Elizabeth D Hay
Journal:  Dev Dyn       Date:  2005-07       Impact factor: 3.780

3.  Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.

Authors:  Einar K Rofstad; Heidi Rasmussen; Kanthi Galappathi; Berit Mathiesen; Kristin Nilsen; Bjørn A Graff
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

4.  Use of brefeldin A to define sites of glycosphingolipid synthesis: GA2/GM2/GD2 synthase is trans to the brefeldin A block.

Authors:  W W Young; M S Lutz; S E Mills; S Lechler-Osborn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Transformation by rous sarcoma virus: effects on cellular glycolipids.

Authors:  S I Hakomori; T Saito; P K Vogt
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

6.  GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.

Authors:  M Ono; K Handa; S Sonnino; D A Withers; H Nagai; S Hakomori
Journal:  Biochemistry       Date:  2001-05-29       Impact factor: 3.162

Review 7.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

8.  Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?

Authors:  Eva A Turley; Mandana Veiseh; Derek C Radisky; Mina J Bissell
Journal:  Nat Clin Pract Oncol       Date:  2008-03-18

9.  Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.

Authors:  S C Kirkland
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

10.  GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells.

Authors:  Alessandro Prinetti; Massimo Aureli; Giuditta Illuzzi; Simona Prioni; Valentina Nocco; Federica Scandroglio; Nicoletta Gagliano; Giovanni Tredici; Virginia Rodriguez-Menendez; Vanna Chigorno; Sandro Sonnino
Journal:  Glycobiology       Date:  2009-09-16       Impact factor: 4.313

View more
  29 in total

1.  Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.

Authors:  Leonardo Freire-de-Lima; Kirill Gelfenbeyn; Yao Ding; Ulla Mandel; Henrik Clausen; Kazuko Handa; Sen-Itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy.

Authors:  Xiang Li; Dongliang Li; Xingchen Pang; Ganglong Yang; H Joachim Deeg; Feng Guan
Journal:  Exp Hematol       Date:  2015-05-01       Impact factor: 3.084

Review 3.  Cancer stem cells: potential target for bioactive food components.

Authors:  Young S Kim; William Farrar; Nancy H Colburn; John A Milner
Journal:  J Nutr Biochem       Date:  2012-07       Impact factor: 6.048

4.  Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition.

Authors:  Keiichiro Sakuma; Masahiro Aoki; Reiji Kannagi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

5.  Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.

Authors:  Jun Du; Senlian Hong; Lu Dong; Bo Cheng; Liang Lin; Bing Zhao; Ye-Guang Chen; Xing Chen
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

6.  Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism.

Authors:  Daniel Mathow; Federica Chessa; Mariona Rabionet; Sylvia Kaden; Richard Jennemann; Roger Sandhoff; Hermann-Josef Gröne; Alexander Feuerborn
Journal:  EMBO Rep       Date:  2015-02-02       Impact factor: 8.807

7.  Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.

Authors:  Yuh-Jin Liang; Yao Ding; Steven B Levery; Marlin Lobaton; Kazuko Handa; Sen-itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

8.  Differential effects of Pax3 on expression of polysialyltransferases STX and PST in TGF-β-treated normal murine mammary gland cells.

Authors:  Dong Guo; Jia Guo; Xiang Li; Feng Guan
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 9.  Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.

Authors:  Ming-Yi Ho; Alice L Yu; John Yu
Journal:  Glycoconj J       Date:  2016-08-22       Impact factor: 2.916

10.  Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.

Authors:  Eduardo J Salustiano; Kelli M da Costa; Leonardo Freire-de-Lima; Lucia Mendonça-Previato; José O Previato
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.